查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1934251

深部腦部刺激設備市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品類型、應用、最終用戶、地區和競爭格局分類，2021-2031年）

Deep Brain Stimulation Devices Market - Global Industry Size, Share, Trends, Opportunity and Forecast Segmented By Product Type, By Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球深部腦部刺激市場預計將從 2025 年的 15.6 億美元成長到 2031 年的 27.7 億美元，複合年成長率達到 10.04%。

這些植入式系統透過向特定腦區傳遞電脈衝來調節神經活動並控制神經系統疾病。市場成長主要受帕金森氏症和癲癇等疾病日益普遍以及全球人口老化（老年人更容易患神經退化性疾病）的推動。此外，患者對先進神經系統治療的認知不斷提高也促進了全球此類系統的普及。世界衛生組織（世衛組織）報告稱，到2024年，全球約有5,000萬人將受到癲癇的影響，凸顯了有效治療方法的緊迫性。

市場概覽
預測期 2027-2031
市場規模：2025年 15.6億美元
市場規模：2031年 27.7億美元
複合年成長率：2026-2031年 10.04%
成長最快的細分市場 雙通道深部腦部刺激器
最大的市場 亞太地區

然而，高昂的設備成本和複雜的法規環境構成了市場擴張的重大障礙。植入和後續維護帶來的沉重經濟負擔限制了設備的普及，尤其是在醫療預算有限的開發中國家。此外，手術的潛在風險以及設備編程所需的技術複雜性也令患者和醫療服務提供者望而卻步，阻礙了市場滲透。

市場促進因素

包括帕金森氏症在內的神經退化性疾病盛行率不斷上升，是推動腦部深部刺激（DBS）市場成長的主要因素，也因此迫切需要可擴展的慢性運動功能管理治療方法。全球人口老化加劇了複雜神經系統疾病的發生率，促使人們尋求比單純藥物治療效果更好的長期治療方案。這項負擔十分沉重；根據世界衛生組織（WHO）2024年3月發布的《世界神經病學現況報告》，目前全球有超過30億人患有神經系統疾病，這是導致殘疾和疾病的主要原因之一。不斷擴大的患者群體凸顯了植入式神經調控設備的臨床緊迫性，尤其是在傳統藥物療法無法提供充分緩解或引起嚴重副作用的情況下。

同時，DBS設備小型化和電池續航時間延長的技術創新正在革新該領域，突破了傳統設備尺寸和維護的限制。製造商正優先研發更小巧、可充電的植入式脈衝產生器（IPG），以提高病患舒適度並延長使用壽命。例如，雅培公司在2024年1月發布的新聞稿中宣布其Liberta RC™ DBS系統獲得FDA核准，並指出該新型設備配備的電池在典型充電後可續航37天，顯著減少了患者頻繁操作設備的需要。這些技術進步正在轉化為行業領先企業的財務成功。 2024年5月，Medtronic報告稱，其腦調控部門實現了兩位數的低段有機收入成長，這反映了這些現代化刺激技術在全球範圍內的廣泛應用。

市場挑戰

高昂的設備成本和複雜的法規結構是全球深部腦部刺激市場成長的主要障礙。手術、設備本身以及必要的術後程序設定都需要大量的資金投入，這給患者和醫療服務提供者都設置了很高的進入門檻。在許多醫療體系中，嚴格的報銷政策和預算限制迫使醫生在考慮深部腦部刺激之前必須嘗試所有其他治療方法，從而延遲或阻礙了該療法的普及。這種經濟上的阻礙限制了市場規模，並使很大一部分患者，特別是那些自付費用高昂的發展中地區患者，難以負擔這項療法。

神經退化性疾病的治療帶來了巨大的經濟負擔，凸顯了這項經濟挑戰的嚴峻。加拿大帕金森氏症協會估計，到2024年，帕金森氏症造成的經濟負擔總額將達到33億加元，其中約90%的負擔由患者及其家庭承擔。這種沉重的個人負擔直接阻礙了諸如腦深部刺激（DBS）等昂貴醫療技術的普及，限制了市場滲透率，並降低了整個行業的收入。

市場趨勢

深部腦部刺激療法的應用範圍已顯著擴展，涵蓋神經精神和認知障礙，使其適用於帕金森氏症等傳統運動障礙以外的更多患者群體。業內相關人員正加大對臨床試驗的投入，以檢驗神經調控療法對複雜精神疾病（例如藥物治療無效的難治性憂鬱症(TRD)）的療效。這一趨勢標誌著治療策略從控制運動症狀轉向調節情緒和認知迴路。例如，根據雅培公司2024年9月發布的新聞稿，該公司已啟動一項關鍵的TRANSCEND研究，該研究招募了100名受試者，旨在評估深部腦部刺激療法治療難治性憂鬱症患者的安全性和有效性。

同時，遠端患者管理和遠端程式設計平台的整合正成為克服地域障礙、提高術後護理效率的關鍵趨勢。新型數位生態系統使臨床醫生能夠遠端調整刺激參數並監測患者病情，從而顯著減輕了以往需要頻繁前往診所進行微調的患者的負擔。這種能力對於擴大治療覆蓋範圍，惠及專科醫師稀缺的低度開發地區至關重要。正如雅培公司在2024年1月發布的關於其Liberta RC™ DBS系統的新聞稿中所指出的，內部研究表明，市場對互聯醫療解決方案有著巨大的需求，因為美國DBS患者平均需要奔波150英里以上才能見到運動障礙專科醫生。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球深部腦部刺激設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（雙通道深部腦部刺激器、單通道深部腦部刺激器）
    • 依類型（可充電式、不可充電式）
    • 因使用（帕金森氏症、癲癇、自發性震顫、肌肌張力不全症失調、強迫症）
    • 依最終使用者（醫院、門診手術中心、神經科科診所等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美深部腦部刺激市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲深部腦部刺激市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區深部腦部刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲深部腦部刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲深部腦刺激市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球深部腦部刺激設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • NeuroPace, Inc.
  • Beijing PINS Medical Co., Ltd.
  • SceneRay Corporation Ltd.
  • Renishaw plc
  • LivaNova plc
  • Functional Neuromodulation Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 5026

The Global Deep Brain Stimulation Devices Market is projected to expand from USD 1.56 Billion in 2025 to USD 2.77 Billion by 2031, achieving a compound annual growth rate of 10.04%. These implantable systems function by transmitting electrical impulses to specific brain regions to regulate neural activity and manage neurological disorders. The market's growth is largely fueled by the increasing prevalence of conditions such as Parkinson's disease and epilepsy, coupled with an aging global population susceptible to neurodegenerative ailments. Additionally, growing patient awareness regarding advanced neurological treatments supports higher adoption rates worldwide. Highlighting the urgent need for effective therapeutic solutions, the World Health Organization reported in 2024 that epilepsy affects approximately 50 million people globally.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.56 Billion
Market Size 2031USD 2.77 Billion
CAGR 2026-203110.04%
Fastest Growing SegmentDual-Channel Deep Brain Stimulator
Largest MarketAsia Pacific

Conversely, high equipment costs and intricate regulatory environments pose significant barriers to market expansion. The substantial financial load associated with implantation and ongoing maintenance restricts accessibility, particularly in developing economies facing healthcare budget constraints. Furthermore, potential surgical risks and the technical complexity involved in device programming can discourage both patients and healthcare providers, thereby hindering broader market penetration.

Market Driver

The rising incidence of Parkinson's disease and other neurodegenerative conditions acts as a primary catalyst for the growth of the Deep Brain Stimulation (DBS) market, creating a critical need for scalable interventions in chronic movement management. As global demographics shift towards an older population, the frequency of complex neurological disorders is increasing, driving demand for long-term therapeutic solutions that offer better results than medication alone. This burden is significant; the World Health Organization's March 2024 'Global Status Report on Neurology' states that neurological conditions now impact over 3 billion individuals worldwide, ranking as the leading cause of disability and ill health. This expanding patient pool underscores the clinical urgency for implantable neuromodulation devices, especially when traditional pharmacological treatments fail to provide adequate relief or cause severe side effects.

Simultaneously, technological innovations in DBS device miniaturization and battery longevity are revolutionizing the sector by overcoming historical limitations related to device size and maintenance. Manufacturers are prioritizing the creation of smaller, rechargeable implantable pulse generators (IPGs) that enhance patient comfort and extend operational life. For example, according to Abbott's January 2024 press release regarding the FDA approval of the Liberta RC(TM) DBS System, the new device features a battery capable of lasting 37 days between charges under normal settings, drastically reducing the need for frequent patient interaction. These engineering advancements are translating into financial success for industry leaders; Medtronic reported in May 2024 that its Brain Modulation division achieved low-double digit organic revenue growth, reflecting strong global adoption of these modernized stimulation technologies.

Market Challenge

High device costs and complex regulatory frameworks constitute a major obstacle to the growth of the Global Deep Brain Stimulation Devices Market. The significant capital required for the surgical procedure, the device itself, and necessary post-operative programming establishes a high barrier to entry for both patients and healthcare providers. In many healthcare systems, strict reimbursement policies and budget limitations force physicians to exhaust all pharmacological options before considering DBS, thereby delaying or preventing the adoption of this therapy. This economic friction restricts the market size, as the therapy remains financially out of reach for a vast segment of the patient population, particularly in developing regions where out-of-pocket expenses are prohibitive.

The magnitude of this financial challenge is highlighted by the immense economic pressure placed on those managing neurodegenerative conditions. According to Parkinson Canada in 2024, the total economic burden of Parkinson's disease is estimated at $3.3 billion, with patients and their families bearing nearly 90% of these costs. This heavy personal financial liability directly discourages the uptake of expensive medical technologies like DBS, reducing widespread market penetration and dampening overall industry revenue.

Market Trends

The scope of Deep Brain Stimulation is significantly widening to include neuropsychiatric and cognitive disorders, extending the addressable patient population beyond traditional movement disorders like Parkinson's disease. Industry participants are increasingly investing in clinical trials to validate neuromodulation for complex psychiatric conditions, such as Treatment-Resistant Depression (TRD), where pharmacological interventions often fail. This trend marks a pivotal transition from managing motor symptoms to modifying mood and cognitive circuits. For instance, according to an Abbott press release in September 2024, the company initiated the pivotal TRANSCEND study to enroll 100 participants to evaluate the safety and effectiveness of DBS therapy for patients suffering from treatment-resistant depression.

Concurrently, the integration of remote patient management and tele-programming platforms is emerging as a critical trend to overcome geographical barriers and improve postoperative care efficiency. New digital ecosystems allow clinicians to adjust stimulation parameters and monitor patient diagnostics virtually, significantly reducing the logistical burden on patients who previously required frequent in-clinic visits for fine-tuning. This capability is essential for expanding therapy access to underserved regions where specialists are scarce. As noted in Abbott's January 2024 press release for the Liberta RC(TM) DBS System, internal research indicated that the average DBS user in the United States must travel more than 150 miles to access a movement disorder specialist, underscoring the vital market need for connected care solutions.

Key Market Players

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • NeuroPace, Inc.
  • Beijing PINS Medical Co., Ltd.
  • SceneRay Corporation Ltd.
  • Renishaw plc
  • LivaNova plc
  • Functional Neuromodulation Ltd.

Report Scope

In this report, the Global Deep Brain Stimulation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Deep Brain Stimulation Devices Market, By Product Type

  • Dual-channel Deep Brain Stimulator
  • Single-channel Deep Brain Stimulator

Deep Brain Stimulation Devices Market, By Type

  • Rechargeable
  • Non-Rechargeable

Deep Brain Stimulation Devices Market, By Application

  • Parkinson's Disease
  • Epilepsy
  • Essential Tremor
  • Dystonia
  • Obsessive Compulsive Disorder

Deep Brain Stimulation Devices Market, By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Neurological Clinics
  • Others

Deep Brain Stimulation Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Deep Brain Stimulation Devices Market.

Available Customizations:

Global Deep Brain Stimulation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Deep Brain Stimulation Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Dual-channel Deep Brain Stimulator, Single-channel Deep Brain Stimulator)
    • 5.2.2. By Type (Rechargeable, Non-Rechargeable)
    • 5.2.3. By Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder)
    • 5.2.4. By End User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Deep Brain Stimulation Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Deep Brain Stimulation Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Deep Brain Stimulation Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Deep Brain Stimulation Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Deep Brain Stimulation Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Deep Brain Stimulation Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Deep Brain Stimulation Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Deep Brain Stimulation Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Deep Brain Stimulation Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Deep Brain Stimulation Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Deep Brain Stimulation Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Deep Brain Stimulation Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Deep Brain Stimulation Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Deep Brain Stimulation Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Deep Brain Stimulation Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Deep Brain Stimulation Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Deep Brain Stimulation Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Deep Brain Stimulation Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Deep Brain Stimulation Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Deep Brain Stimulation Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Deep Brain Stimulation Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Deep Brain Stimulation Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Deep Brain Stimulation Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Deep Brain Stimulation Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Deep Brain Stimulation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boston Scientific Corporation
  • 15.3. Abbott Laboratories
  • 15.4. Aleva Neurotherapeutics SA
  • 15.5. NeuroPace, Inc.
  • 15.6. Beijing PINS Medical Co., Ltd.
  • 15.7. SceneRay Corporation Ltd.
  • 15.8. Renishaw plc
  • 15.9. LivaNova plc
  • 15.10. Functional Neuromodulation Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer